Frankfurt - Delayed Quote EUR
Atai Life Sciences N.V. (9VC.F)
1.3700
+0.1490
+(12.20%)
As of 5:08:32 PM GMT+2. Market Open.
Insider Roster
Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.
| Individual or Entity | Most Recent Transaction | Date | Shares Owned as of Transaction Date |
|---|---|---|---|
| APEIRON INVESTMENT GROUP LTD. Beneficial Owner of more than 10% of a Class of Security | Purchase | Mar 24, 2025 | -- |
| BRAND FLORIAN Chief Executive Officer | Sale | May 16, 2024 | 331,030 |
| CRAIG KEVIN JAMES M.D. Officer | Sale | Mar 21, 2025 | 8,437 |
| JOHNSON ANNE NAGENGAST Chief Financial Officer | Sale | Mar 21, 2025 | 140,045 |
| KIRPEKAR SAHIL Officer | Sale | Mar 21, 2025 | 115,636 |
| RAO SRINIVAS Chief Executive Officer | Sale | Mar 21, 2025 | 216,442 |
| SHORT GLENN FRANK PH.D. Officer | Sale | Mar 21, 2025 | 42,333 |
Related Tickers
ADXN Addex Therapeutics Ltd
7.60
0.00%
ANL Adlai Nortye Ltd.
2.0500
+12.02%
9606.HK Duality Biotherapeutics, Inc.
218.600
-0.46%
VALN Valneva SE
7.00
+0.86%
GLPG Galapagos NV
25.39
+1.24%
GUBRA.CO Gubra A/S
361.20
+3.44%
AFMD Affimed N.V.
0.7638
+3.36%
ALMS Alumis Inc.
5.0000
+0.60%
REPL Replimune Group, Inc.
9.02
+3.56%
YMAB Y-mAbs Therapeutics, Inc.
4.1800
-1.88%